Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: parent exact "NPJ VACCINES" Add to list Journal Article A1 open access QuilA® adjuvanted Coxevac® sustains Th1-CD8+-type immunity and increases protection in Coxiella burnetii-challenged goats Sara Tomaiuolo (UGent) , Wiebke Jansen, Susana Soares Martins, Bert Devriendt (UGent) , Eric Cox (UGent) and Marcella Mori (2023) NPJ VACCINES. 8(1). Add to list Journal Article A1 open access Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase João Paulo Portela Catani, Emma Job (UGent) , Tine Ysenbaert (UGent) , Anouk Smet (UGent) , Satyajit Ray, Lauren LaRue, Svetlana Stegalkina, Mario Barro, Thorsten U. Vogel and Xavier Saelens (UGent) (2022) NPJ VACCINES. 7(1). Add to list Journal Article A1 open access Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent) (2020) NPJ VACCINES. 5(1). Add to list Journal Article A1 open access Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection Kristien Van Reeth (UGent) , José Carlos Mancera Gracia (UGent) , Ivan Trus (UGent) , Lieve Sys (UGent) , Gerwin Claes (UGent) , Han Versnaeyen (UGent) , Eric Cox (UGent) , Florian Krammer and Yu Qiu (UGent) (2017) NPJ VACCINES. 2. Add to list Journal Article A1 open access Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity Margherita Coccia, Catherine Collignon, Caroline Hervé, Aurélie Chalon, Iain Welsby, Sophie Detienne, Mary van Helden (UGent) , Sheetij Dutta, Christopher J Genito, Norman C Waters, et al. (2017) NPJ VACCINES. 2(1).